CALC Stock — CalciMedica Inc.: Cash, EV, Pipeline

Share price

$1.92

Market cap

$13.1M

Cash

$18.6M

Enterprise value

-$5.5M

Balance sheet

Cash	$18.6M
Debt	$0.0M
Net cash	$18.6M
Enterprise value	-$5.5M
Basic shares	30.7M shares
Fully diluted shares	43.7M shares
Fully diluted market cap	$83.9M
Cash per share	$0.61

Cash figures as of 2026-06-30. Database snapshot: 2026-09-21.

Price history

Loading CALC daily closes…

Loading price history…

Pipeline assets

Auxora

Phase 2 · Active Modality: small molecule (IV)

Aliases CM4620

Target CRAC channels

Partnerships not disclosed

Indications

Acute pancreatitis (AP) (Phase 2)
Pulmonary arterial hypertension (PAH) (Phase 1)
Pediatric asparaginase-induced pancreatic toxicity (AIPT) (Phase 2)
Acute kidney injury (AKI) with acute hypoxemic respiratory failure (AHRF) (Phase 2)
Severe COVID-19 pneumonia (Phase 2)

Catalysts

— None
— None
— None

Status note Active ingredient is zegocractin (formerly CM4620). Completed Phase 2b CARPO in AP. KOURAGE Phase 2 in AKI/AHRF discontinued January 2026; no current plans to resume AKI dosing. Initiation of next AP trial subject to obtaining additional financing; going-concern warning disclosed.

CM5480

Preclinical · Active Modality: small molecule (oral)

Target CRAC channels

Partnerships not disclosed

Indications

Pulmonary arterial hypertension and other chronic pulmonary hypertension (Preclinical)

Catalysts

— None

Status note Selective oral CRAC channel inhibitor in IND-enabling development for PAH. Exploratory preclinical work in chronic pancreatitis, rheumatoid arthritis, ulcerative colitis and allergic asthma.

Per-asset detail extracted from the 10-Q filed 2026-08-11. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.

No lead program on file for this company.

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT04195347	Phase 2	Recruiting	Collaborator	St. Jude Children's Research Hospital	—	Acute Pancreatitis	—

Sponsor-matched active trials from ClinicalTrials.gov (0 as sponsor, 1 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 1 active trials for St. Jude Children's Research Hospital on ClinicalTrials.gov

No specialist-fund holders in 13F data for this company.

CALC — CalciMedica Inc.

Balance sheet

Price history

Pipeline assets

Active clinical trials